Google Cloud and Liberty Global Forge Strategic AI Partnership to Transform European Telecom Services 
Boeing Signals Progress on Delayed 777X Program With Planned April First Flight 
Novo Nordisk Warns of Profit Decline as Wegovy Faces U.S. Price Pressure and Rising Competition 
SpaceX Reports $8 Billion Profit as IPO Plans and Starlink Growth Fuel Valuation Buzz 
Using the Economic Calendar to Reduce Surprise Driven Losses in Forex 
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
SoftBank and Intel Partner to Develop Next-Generation Memory Chips for AI Data Centers 
Boeing Secures New Labor Contract With Former Spirit AeroSystems Employees 
NRW Holdings Shares Surge After Securing Major Rio Tinto Contract and New Project Wins 
Nvidia Confirms Major OpenAI Investment Amid AI Funding Race 
Denso Cuts Profit Forecast Amid U.S. Tariffs and Rising Costs 
Tesla Launches New Model Y Variant in the US Starting at $41,990 
Qantas to Sell Jetstar Japan Stake as It Refocuses on Core Australian Operations 
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate 
Disney Board Nears CEO Decision as Josh D’Amaro Emerges as Leading Candidate 
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock 
MOORESTOWN, N.J., Aug. 22, 2017 -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ:TRHC), a healthcare technology company optimizing medication safety by deploying new medication risk mitigation digital software solutions and novel, proprietary medication decision support tools, today announced that Chairman and CEO, Calvin Knowlton, Ph.D., Orsula Knowlton, PharmD, MBA, President, and Chief Financial Officer, Brian Adams, will participate in three upcoming investor conferences.
Mr. Adams is scheduled to present at the Robert W. Baird 2017 Global Healthcare Conference in New York City on Wednesday, September 6, 2017 at 3:10 p.m. ET.
Dr. Knowlton, Dr. Knowlton, and Mr. Adams are scheduled to present at the Wells Fargo 2017 Healthcare Conference in Boston, MA on Thursday, September 7, 2017 at 1:40 p.m. ET. A live audio-only webcast of the presentation will be available on the investor relations section of the Company’s website at ir.trhc.com. The archived webcast and presentation materials will also be available for 90 days at the same URL.
Mr. Adams is scheduled to present at the 2017 Cantor Fitzgerald Global Healthcare Conference in New York City on Tuesday, September 26, 2017 at 2:50 p.m. ET.
About Tabula Rasa HealthCare
Tabula Rasa HealthCare (NASDAQ:TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to personalize and optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. For more information, please visit: www.TRHC.com.
Contact: Investors Bob East or Asher Dewhurst Westwicke Partners 443-213-0500 [email protected] Media Dianne Semingson 215-870-0829 [email protected]
